Product image of Moxifloxacina Bluepharma (Moxifloxacin) supplied by GNH India

Moxifloxacina Bluepharma

Active Ingredient:
Moxifloxacin
Origin:
EU

Moxifloxacina Bluepharma (Moxifloxacin)

Moxifloxacin, the active ingredient in Moxifloxacina Bluepharma, is a fluoroquinolone antibiotic presented as an oral dosage form for systemic use. It treats a range of serious bacterial infections in adult patients.
GNH India supplies Moxifloxacina Bluepharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Bluepharma Genéricos - Comércio De Medicamentos, S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Moxifloxacina Bluepharma is a fluoroquinolone antibiotic indicated for several bacterial infections.

  • Community‑acquired bacterial pneumonia: effective treatment of the infection in adults.
  • Acute bacterial sinusitis: eradicates the causative pathogens and relieves symptoms.
  • Acute bacterial exacerbation of chronic bronchitis: reduces bacterial load and improves lung function.
  • Skin and skin structure infections: combats susceptible Gram‑positive and Gram‑negative organisms.
  • Intra‑abdominal infections: provides broad‑spectrum coverage for mixed aerobic and anaerobic flora.

How It Works

  • Moxifloxacin inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, enzymes essential for DNA replication, transcription, and repair. By stabilizing the enzyme‑DNA complex, it prevents the resealing of DNA strands, leading to bacterial cell death and a bactericidal effect against a wide range of Gram‑positive and Gram‑negative organisms.

Side Effects

Moxifloxacina Bluepharma may cause a variety of adverse reactions.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Diarrhea: loose stools, sometimes watery.
  • Headache: transient cranial discomfort.
  • Dizziness: sensation of light‑headedness.
  • Abdominal pain: cramping or discomfort.
  • Rash: mild skin erythema.

Serious or Rare Side Effects

  • Tendon rupture: especially Achilles tendon, may occur without warning.
  • QT interval prolongation: risk of cardiac arrhythmias.
  • Clostridioides difficile infection: severe colitis.
  • Severe allergic reactions: anaphylaxis, angioedema.
  • Hepatic dysfunction: elevated liver enzymes or hepatitis.
  • Peripheral neuropathy: numbness or tingling in extremities.

Precautions & Warnings

Before prescribing Moxifloxacina Bluepharma, clinicians should consider several safety aspects.

  • Renal impairment: adjust therapy as needed and monitor renal function.
  • History of tendon disorders: avoid use due to increased risk of tendon rupture.
  • Cardiac arrhythmias: monitor QT interval, especially with other QT‑prolonging agents.
  • Pregnancy and lactation: use only if benefits outweigh potential risks.
  • Concomitant antacids: separate administration by at least 2 hours to ensure absorption.
  • Store at ambient temperature: keep in the original pack, protect from moisture and light.

Avoid Interactions

Moxifloxacina Bluepharma can interact with several medicines, requiring careful management.

Major Interactions (Avoid)

  • Corticosteroids: increased risk of tendon rupture.
  • Anticoagulants (e.g., warfarin): enhanced anticoagulant effect, may raise bleeding risk.
  • QT‑prolonging drugs: additive risk of cardiac arrhythmias.
  • Theophylline: moxifloxacin may raise plasma theophylline levels.
  • Non‑steroidal anti‑inflammatory drugs (NSAIDs): potential increase in CNS toxicity.

Moderate Interactions (Monitor Closely)

  • Antacids containing magnesium or aluminum: reduce moxifloxacin absorption.
  • Iron supplements: decrease oral bioavailability.
  • Cyclosporine: may increase moxifloxacin concentrations.
  • Rifampin: may lower efficacy by inducing metabolism.
  • Oral contraceptives: possible reduced effectiveness, advise additional contraceptive measures.

Frequently Asked Questions

Moxifloxacina Bluepharma contains the fluoroquinolone moxifloxacin and is prescribed for a range of serious bacterial infections, including community‑acquired pneumonia, acute bacterial sinusitis, exacerbations of chronic bronchitis, skin and soft‑tissue infections, and intra‑abdominal infections.

Moxifloxacin blocks bacterial DNA gyrase and topoisomerase IV, enzymes required for DNA replication and transcription. This inhibition prevents bacterial DNA from unwinding and resealing, leading to bacterial cell death and a bactericidal effect against many Gram‑positive and Gram‑negative organisms.

The dose is set by the prescribing clinician based on the specific infection, patient age, renal and hepatic function, and other individual factors. No fixed regimen is provided here; the prescriber will decide the appropriate strength and duration.

Safety data in pregnancy and lactation are limited. It should be used only when the expected benefit to the mother outweighs potential risks to the fetus or infant, and only under medical supervision.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Moxifloxacin offers a broader spectrum against anaerobic bacteria and better activity against certain Gram‑positive organisms compared with older agents like ciprofloxacin. Compared with levofloxacin, it has a longer half‑life, allowing once‑daily dosing, but shares similar safety considerations such as tendon and QT‑prolongation risks.

Store the product at ambient temperature, below 25 °C, in its original container. Protect it from moisture, excessive heat and direct sunlight to maintain stability and potency.

The medication is taken orally, usually with a full glass of water. It may be taken with or without food, but antacids or mineral supplements should be spaced at least two hours apart to avoid reduced absorption.

Serious adverse events include tendon rupture (especially Achilles), QT‑interval prolongation leading to arrhythmias, severe Clostridioides difficile‑associated colitis, hypersensitivity reactions such as anaphylaxis, and rare hepatic or peripheral‑nerve toxicity. Patients should be monitored for these signs.

Individuals with a known hypersensitivity to moxifloxacin or any fluoroquinolone, those with a history of tendon disorders related to fluoroquinolone use, patients with uncontrolled arrhythmias or prolonged QT interval, and pregnant or breastfeeding women unless clearly indicated should avoid this medication.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Moxifloxacin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT